Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
159M
-
Number of holders
-
306
-
Total 13F shares, excl. options
-
122M
-
Shares change
-
-2.7M
-
Total reported value, excl. options
-
$4.08B
-
Value change
-
-$99.8M
-
Put/Call ratio
-
0.65
-
Number of buys
-
134
-
Number of sells
-
-147
-
Price
-
$33.54
Significant Holders of IONIS PHARMACEUTICALS INC - COMMON STOCK (IONS) as of Q3 2021
377 filings reported holding IONS - IONIS PHARMACEUTICALS INC - COMMON STOCK as of Q3 2021.
IONIS PHARMACEUTICALS INC - COMMON STOCK (IONS) has 306 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 122M shares
of 159M outstanding shares and own 76.76% of the company stock.
Largest 10 shareholders include FMR LLC (21.2M shares), VANGUARD GROUP INC (11.8M shares), PRICE T ROWE ASSOCIATES INC /MD/ (11.7M shares), Bellevue Group AG (9.35M shares), ARK Investment Management LLC (8.51M shares), BlackRock Inc. (8.12M shares), Clearbridge Investments, LLC (7.33M shares), STATE STREET CORP (3.52M shares), Camber Capital Management LP (2.5M shares), and JPMORGAN CHASE & CO (2.42M shares).
This table shows the top 306 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.